#United States #Innovations #healthcare #Amgen #Thousand Oaks

Amgen's Presentation at Morgan Stanley 24th Annual Global Healthcare Conference

On September 15, 2026, at 11:30 a.m. ET, Amgen will take the stage at the prestigious Morgan Stanley 24th Annual Global Healthcare Conference. This event promises to be a significant platform where Amgen will unveil strategic insights and share updates regarding their groundbreaking healthcare initiatives.

Key Presenters

The presentation will feature key figures from Amgen, including Jay Bradner, the Executive Vice President of Research and Development, and Thomas Dittrich, who serves as the Executive Vice President and Chief Financial Officer. Their combined expertise in biotechnology and financial strategies sets the stage for a compelling discussion on how Amgen is tackling some of the world's most challenging health issues through innovative solutions.

The event is not just limited to conference attendees; it will also be available via a live webcast. This ensures that media members, investors, and the general public have access to the insights shared during the conference. For those unable to attend in real-time, the webcast will be archived, allowing viewers to catch up on the presentation for at least 90 days afterward.

About Amgen

Founded over 45 years ago, Amgen has been at the forefront of the biotechnology industry, headquartered in Thousand Oaks, California. The company is dedicated to discovering, developing, manufacturing, and delivering innovative medications aimed at combating some of the toughest diseases worldwide. Amgen utilizes cutting-edge technology and biopharmaceutical research to enhance treatment capabilities for various conditions, including cancer, inflammatory diseases, cardiovascular problems, and metabolic disorders.

Amgen's commitment to innovation has not gone unnoticed; the company has earned recognition for its workplace culture and innovation from esteemed platforms like Fast Company and Forbes. Moreover, it is a proud member of the Dow Jones Industrial Average® and Nasdaq-100 Index®, reflecting its significant influence and standing in the market.

Looking Ahead

As the conference approaches, anticipation builds for what Amgen will present. Stakeholders are eager to see how the company's ongoing research and its strategic direction will unfold. Amgen's participation in this event showcases its commitment to transparency and engagement with its community, reinforcing its role as a leader in the healthcare industry.

For more detailed information about the presentation, including access to the live stream, visit Amgen's official website at www.amgen.com under the Investors section, where a calendar of events is available. As the anticipation heightens, the healthcare community awaits insights that will likely influence the future of biotechnology and patient care.